Mind Medicine Australia (Mental Health Partner)

ff 050ce877eb3af93012135762dd1ce6b2 ff MMA logo

Mind Medicine Australia (MMA) is a mental health charity that helps to alleviate the suffering caused by mental illness in Australia through expanding the treatment options available to medical practitioners and their patients. We are establishing safe and effective psychedelic-assisted treatments to cure a range of mental illnesses. Our goal is to ensure these treatments become available and accessible through the medical system to help prevent mental illness and suicide.

Key aspects of our strategy to build the ecosystem in Australia include educational events, webinars, screenings and the development of local Chapters around Australia, a major online International Medical Summit (November 2021), the development and delivery of a gold-standard national therapist training course, the development of appropriate legal and ethical frameworks for discussion with regulators, the delivery of reliable sources of pharmaceutical grade psilocybin and MDMA in Australia, clinical roll-outs and the development of the Asia-Pacific Centre for Emerging Mental Health Therapies.

Unlike current treatments such as anti-depressants, which only manage the illness and can have nasty side effects, psilocybin and MDMA assisted therapies have been scientifically proven to be a safe and effective cure for anxiety, depression, end-of-life stress, addictions and PTSD after just a short treatment program. These medicines are also currently being researched for dementia, eating disorders, OCD and a number of other conditions. Research from over 160 trials indicates that the medicines are safe and non-addictive when administered within a medically-controlled environment, and lead to remissions in 60-80% of patients after just 2-3 medicinal sessions in combination with psychotherapy. There have been no adverse events in thousands of patients.

Both medicines have been granted Breakthrough Therapy Status by the FDA in the USA to fast-track their approval. This designation is only given to medicines which may prove to be vastly superior to existing treatments.